PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer.

J Cancer · 2023 · PMC10158510 · PMID 37151397

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

While PPAR-δ has been shown to be expressed in several tissues within human body and is highly significant in the regulation of various functions, this study has provided further elucidation into the role of PPAR-δ and its potential role as a moderate BRCA predictive biomarker.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.